XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Condensed Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents (Note 6) $ 3,002.4 $ 3,657.1
Short-term investments (Note 6) 49.0 24.2
Accounts receivable, net of allowances of $23.9 (2021) and $25.9 (2020) 5,592.8 5,875.3
Other receivables 1,065.8 1,053.7
Inventories 3,660.8 3,980.3
Prepaid expenses and other 3,233.7 2,871.5
Total current assets 16,604.5 17,462.1
Investments (Note 6) 3,232.4 2,966.8
Goodwill 3,877.4 3,766.5
Other intangibles, net 8,087.8 7,450.0
Deferred tax assets 2,649.9 2,830.4
Property and equipment, net of accumulated depreciation of $9,643.4 (2021) and $9,570.7 (2020) 8,630.1 8,681.9
Other noncurrent assets 3,756.2 3,475.4
Total assets 46,838.3 46,633.1
Current Liabilities    
Short-term borrowings and current maturities of long-term debt 4.9 8.7
Accounts payable 1,639.6 1,606.7
Employee compensation 649.9 997.2
Sales rebates and discounts 5,821.4 5,853.0
Dividends payable 0.0 770.6
Income taxes payable 791.6 495.1
Other current liabilities 2,806.8 2,750.3
Total current liabilities 11,714.2 12,481.6
Other Liabilities    
Long-term debt 16,199.6 16,586.6
Accrued retirement benefits (Note 8) 3,969.8 4,094.5
Long-term income taxes payable 3,917.5 3,837.8
Deferred tax liabilities 2,200.6 2,099.9
Other noncurrent liabilities 1,737.3 1,707.5
Total other liabilities 28,024.8 28,326.3
Commitments and Contingencies (Note 9)
Eli Lilly and Company Shareholders’ Equity    
Common stock 599.7 598.2
Additional paid-in capital 6,579.2 6,778.5
Retained earnings 9,181.3 7,830.2
Employee benefit trust (3,013.2) (3,013.2)
Accumulated other comprehensive loss (Note 10) (6,395.6) (6,496.4)
Cost of common stock in treasury (52.7) (55.7)
Total Eli Lilly and Company shareholders’ equity 6,898.7 5,641.6
Noncontrolling interests 200.6 183.6
Total equity 7,099.3 5,825.2
Total liabilities and equity $ 46,838.3 $ 46,633.1